Sangamo Therapeutics : Open Market Sale Agreement - Form 8-K
Sgmo-20230307 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... | March 7, 2023
Source: marketscreener.com
Stay updated with breaking news from Registration Statementon Form. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sgmo-20230307 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... | March 7, 2023